Sanofi unveiled a new bold and unifying corporate brand that supports the modernisation and transformation the company launched in December 2019.
|Sanofi’s new logo with two purple dots is inspired by scientific discovery |
Over the last 50 years, Sanofi has grown into a diverse, global healthcare leader, with a rich heritage of patient-centric science. The history includes the first treatments for many rare diseases and the establishment of care standards in diabetes and cardiovascular diseases.
Sanofi’s commitment to public health has helped protect hundreds of millions of people from influenza every year for decades and pushed polio to the brink of eradication, while its scientific vision has led to breakthrough innovations in the treatment of inflammatory diseases.
With roots in a variety of diverse companies, Sanofi today is the combination of many cultures, identities, and brands.
Its new brand is rooted in this heritage and brings this diverse history together in a single common identity for the first time. This manifestation of the company’s journey highlights an ambitious strategy for the future.
|Sanofi's new ambition |
“As we approach the half-century mark of our company’s existence, we have undertaken the most important transformation and modernisation in our history,” said Paul Hudson, CEO of Sanofi.
“In 2019, we launched our Play to Win strategy, which focuses on applying our platform for innovation to produce first- and best-in-class treatments and vaccines. Our new brand is a natural and important next step in this journey and represents the integrated way in which the company will work to achieve our shared ambition to transform the practice of medicine.”
Current business units Sanofi Pasteur and Sanofi Genzyme, focusing on vaccines and speciality care respectively, and all other acquired brands, will be united under the singular Sanofi name and brand.
These brands have for years symbolised the impact that innovation can have on people’s lives. Thinking, acting, and behaving as a single entity under a new shared purpose and identity will position Sanofi to have a greater impact by applying the resources that exist across the company more strategically to drive innovations that matter.
“With our new brand, we have sought to provide our people, our partners, patients, and healthcare professionals with a clear and strong understanding of who we are and what we are set to achieve,” said Josep Catllà, head of Corporate Affairs at Sanofi.
“Sanofi’s attitude is humble and authentic – and a little bit unconventional too. We believe that our new brand and logo carve out a unique space in the healthcare industry that perfectly represents our new purpose to chase the miracles of science to improve people’s lives.”